Veopoz

pozelimab-bbfg

Approval

ApplicationBLA 761339
Approval dateAug 18, 2023
Approval year2023
SponsorRegeneron Pharmaceuticals

FDA-approved use

To treat patients 1 year old and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Veopoz: